Clinical Trial Update: Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial of an anti GM-2 monoclonal antibody for multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Anti GM-2 Monoclonal Antibody

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED